UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036218
Receipt number R000041257
Scientific Title Effect of test food on triglyceride and LDL-cholesterol level -open trial-
Date of disclosure of the study information 2019/03/16
Last modified on 2019/04/24 11:35:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of test food on triglyceride and LDL-cholesterol level -open trial-

Acronym

Effect of test food on triglyceride and LDL-cholesterol level -open trial-

Scientific Title

Effect of test food on triglyceride and LDL-cholesterol level -open trial-

Scientific Title:Acronym

Effect of test food on triglyceride and LDL-cholesterol level -open trial-

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of the intake of test food on triglyceride and LDL-cholesterol level

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

LDL-cholesterol level

Key secondary outcomes

Triglyceride, total cholesterol, waist circumference


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intake of test food (low dose) for 12 consecutive weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

64 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Males and females from 20 to 64 years of age
(2) Serum LDL- cholesterol level are ranged from 120 mg/dL to 139 mg/dL

Key exclusion criteria

(1) Subjects who routinely take foods or medicines affecting the test result
(2) Subjects who drink green tea more than once a day
(3) Subjects who have a disease requiring regular medication or a history of serious diseases for which medication was required
(4) Subjects who have under treatment or a history of serious disease (e.g., diabetes, or liver disease, kidney disease, or heart disease)
(5) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire
(6) Subjects having possibilities for emerging allergy related to the study
(7) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination
(8) Subjects participating in other clinical study
(9) Females who are known or suspected to be pregnant, breastfeeding or desire to become pregnant during the trial period
(10) Subjects who are judged unfit to enroll in this trial by the investigator

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Masaharu
Middle name
Last name Ohkawara

Organization

Satoen Co., LTD.

Division name

none

Zip code

421-1392

Address

1057 Ohhara, Aoi-ku, Shizuoka, Japan

TEL

054-270-1336

Email

masaharu-ohkawara@satoen.co.jp


Public contact

Name of contact person

1st name Hiroyasu
Middle name
Last name Shimada

Organization

TTC Co., Ltd.

Division name

Clinical Research Planning Department

Zip code

150-0021

Address

1-20-2 Ebisu-nishi, Shibuya-ku, Tokyo, Japan

TEL

03-5459-5329

Homepage URL


Email

h.shimada@ttc-tokyo.co.jp


Sponsor or person

Institute

TTC Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Satoen Co., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Aisei Hospital Ueno Clinic Reserch Ethics Committee

Address

2-18-6, Higasiueno, Taito-ku, Tokyo, Japan

Tel

03-6455-0880

Email

t.saito@ttc-smo.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 03 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 02 Month 28 Day

Date of IRB

2019 Year 02 Month 28 Day

Anticipated trial start date

2019 Year 03 Month 17 Day

Last follow-up date

2019 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 03 Month 15 Day

Last modified on

2019 Year 04 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041257


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name